*Autologous immune enhancement therapy

September 2000). "Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial ... June 2002). "Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced ... "Adoptive immunotherapy of cancer: accomplishments and prospects". Cancer Treat Rep. 68 (1): 233-55. PMID 6362866. Yang Q, ... AIET in NCRM Immunotherapy in Malaysia AIET experience by Nilai Cancer Centre, Malaysia A patient blog: AIET help cure sarcoma ...

*Adoptive cell transfer

Adoptive Transfer at the US National Library of Medicine Medical Subject Headings (MeSH) Adoptive Immunotherapy at the US ... Gattinoni L, Powell DJ, Rosenberg SA, Restifo NP (May 2006). "Adoptive immunotherapy for cancer: building on success". Nature ... Rosenberg SA, Restifo NP (April 2015). "Adoptive cell transfer as personalized immunotherapy for human cancer". Science. 348 ( ... Adoptive cell transfer (ACT) is the transfer of cells into a patient. The cells may have originated from the patient or from ...

*Zinc finger nuclease

"Genetic engineering of T cells for adoptive immunotherapy". Immunologic research. 42 (1-3): 166-181. doi:10.1007/s12026-008- ...

*Steven Rosenberg

Rosenberg has pioneered the use of adoptive immunotherapy. Rosenberg received his B.A. (biology, 1960) and M.D. (1963) degrees ... He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies and the development of ... with developing the use of IL-2 and immune cells for the treatment of patients with melanoma in a procedure termed adoptive ... His research has focused on the immunotherapy of cancer. https://www.nytimes.com/2016/08/02/health/cancer-cell-therapy-immune- ...

*Cancer immunotherapy

Adoptive T-cell therapy is a form of passive immunization by the transfusion of T-cells (adoptive cell transfer). They are ... What is Cancer Immunotherapy Association for Immunotherapy of Cancer Society for Immunotherapy of Cancer "And Then There Were ... Restifo NP, Dudley ME, Rosenberg SA (March 2012). "Adoptive immunotherapy for cancer: harnessing the T cell response". Nature ... Other modes of enhancing [adoptive] immuno-therapy include targeting so-called intrinsic checkpoint blockades e.g. CISH. ...

*Nicholas P. Restifo

Epub ahead of print] Restifo NP, Dudley ME, Rosenberg SA (March 2012). "Adoptive immunotherapy for cancer: harnessing the T ... Restifo NP, Dudley ME, Rosenberg SA (March 2012). "Adoptive immunotherapy for cancer: harnessing the T cell response". Nature ... Restifo has been a pioneer in the use of T cell-based immunotherapy. Dr. Restifo was born in Columbus, Ohio. He grew up in a ... The adoptive transfer of tumor-specific effector T cells knocked out or knocked down for CISH resulted in a significant ...

*Tumor antigen

Cancer immunotherapy Restifo, NP; Dudley, ME; Rosenberg, SA (Mar 22, 2012). "Adoptive immunotherapy for cancer: harnessing the ... Coulie PG, Hanagiri T, Takanoyama M: From Tumor Antigens to Immunotherapy. Int J Clin Oncol 6:163, 2001. Chapter on tumor ...

*Antonio Siccardi

"Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging". Cancer research. 60 (15): 4211-5. PMID 10945632 ...

*Telomerase

Barsov EV (2011). "Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy". Immunotherapy. 3 (3 ... Immunotherapy successfully treats some kinds of cancer, such as melanoma. This treatment involves manipulating a human's immune ... It must be combined with surgery, radiation, chemotherapy or immunotherapy. Cells may reduce their telomere length by only 50- ... Patel, Kunal P.; Robert H., Vonderheide (2004). "Telomerase as a tumor-associated antigen for cancer immunotherapy". ...

*Primary immunodeficiency

"Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes". Journal of Allergy and ...

*Tumor antigens recognized by T lymphocytes

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes ". Science. 233: 1318-1321. Wu R., ... Adoptive transfer of TILs can increase the survival of melanoma patients when it is used as an adjuvant therapy, i.e. after a ... Adoptive transfer involves either collecting from patients intratumoral or blood T cells, stimulate them in vitro against ... Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survival ". Journal of Immunology Research. 2014 ...

*Cytokine-induced killer cell

Jäkel, Clara E; Schmidt-Wolf, Ingo GH (July 2014). "An update on new adoptive immunotherapy strategies for solid tumors with ... "Feasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantation". Biology of blood and marrow ... cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)". Journal of Cancer Research and ... immunotherapy : CII. 53 (11): 1018-26. doi:10.1007/s00262-004-0554-4. PMID 15185013. Hombach, AA; Rappl, G; Abken, H (December ...

*Immunotherapy

Kang N, Zhou J, Zhang T, Wang L, Lu F, Cui Y, Cui L, He W (August 2009). "Adoptive immunotherapy of lung cancer with ... while immunotherapies that reduce or suppress are classified as suppression immunotherapies. In recent years, immunotherapy has ... Doskali M, Tanaka Y, Ohira M, Ishiyama K, Tashiro H, Chayama K, Ohdan H (March 2011). "Possibility of adoptive immunotherapy ... Immunotherapy may produce long-term benefits. Immunotherapy is partly effective in some people and ineffective in others, but ...

*Epithelioid sarcoma

Adoptive immunotherapy seeks to expand a population of the body's T-cells that will recognize a specific tumor antigen. T-cells ... Immunotherapy is the strategy of using the body's own immune system to fight cancer. It usually involves "training" or " ... Different immunotherapies can include manipulation of the body's T-cells, NK cells, or Dendritic cells so they are more ... Hu, James S; Skeate, Joseph G; Kast, Wijbe Martin (2014). "Immunotherapy in sarcoma: A brief review". Sarcoma Research ...

*NK-92

Three phase I clinical trials, led by experts in adoptive immunotherapy of cancer, have so far yielded excellent results. Hans ... J Hematother Stem Cell Res 2001;10:369-83 Tam YK, Miyagawa B, Ho VC, Klingemann H-G. Immunotherapy of malignant melanoma in a ... Cytotherapy 2008;10:625-32 Tonn T, Becker S, Esser R, Schwabe D, Seifried E. Cellular immunotherapy of malignancies using the ...

*Checkpoint inhibitor

Other modes of enhancing [adoptive] immunotherapy include targeting so-called intrinsic checkpoint blockades e.g. CISH. ... "A rush for immunotherapy cancer drugs means new bedfellows". The Economist. Retrieved 2017-08-25. "Enrolling the immune system ... Cancer immunotherapy Chimeric antigen receptor Pardoll DM (March 2012). "The blockade of immune checkpoints in cancer ... Pollack A (2016-05-18). "F.D.A. Approves an Immunotherapy Drug for Bladder Cancer". The New York Times. ISSN 0362-4331. ...

*Donor lymphocyte infusion

Donor lymphocyte (or leukocyte) infusion (DLI) or buffy coat infusion is a form of adoptive immunotherapy used after ...

*Chimeric antigen receptor

Yoon, S H; Lee, J M; Cho, H I; Kim, E K; Kim, H S; Park, M Y; Kim, T G (2008). "Adoptive immunotherapy using human peripheral ... making it feasible as a safe approach to produce CAR T cells for cancer immunotherapy. Although adoptive transfer of CAR- ... A CAR therapy for cancer, using a technique called adoptive cell transfer, has been approved by the US Food and Drug ... A common method for engineering CAR-T cells for cancer immunotherapy is to use viral vectors such as retrovirus, lentivirus or ...

*Georges Mathé

That event made him aware of the possibility and necessity of developing active and adoptive immunotherapy and applying it to ... "adoptive immunotherapy," to describe how a person's own immune system can be used to combat cancer and other diseases. Dr. ... In the early 1990s, conscious of the immunological nature of HIV/AIDS, Mathé applied immunotherapy to a dozen patients. He also ... Cancer Immunotherapy, New York, 1976, Springer: Mathé Cancer chemo-and immuno pharmacology, Springer Verlag, Heidelberg 1980; " ...

*Miltenyi Biotec

... adoptive immunotherapy and graft engineering. Since 1997, more than 35,000 clinical treatments on the basis of MACS Technology ...

*List of MeSH codes (E02)

... adoptive transfer MeSH E02.095.520.400.330.050.400 --- immunotherapy, adoptive MeSH E02.095.520.400.470 --- immunization ... schedule MeSH E02.095.520.400.485 --- immunization, secondary MeSH E02.095.520.400.530 --- immunotherapy, active MeSH E02.095. ...

*Index of oncology articles

... cellular adoptive immunotherapy - cellular metabolism - cellulitis - central nervous system primitive neuroectodermal tumor - ... immunotherapy - immunotoxin - in situ cancer - incisional biopsy - incomplete Freund's adjuvant - indinavir - indium In 111 ...

*ALECSAT

The latter method is utilized for ALECSAT to treat cancer by adoptive T-cell immunotherapy. Refer to the adjacent diagram for a ... Research on adoptive transfer in melanoma patients laid the groundwork for companies focusing on adoptive transfer research in ... In a study run at the University de la Sante, the adoptive transfer of cloned T cells in "in vitro immunization" caused ... "Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of ...

*Genome editing

... adoptive T-cell immunotherapies". Cancer Research. 75: canres.3321.2014. doi:10.1158/0008-5472.CAN-14-3321. ISSN 0008-5472. ... "A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy". Molecular Therapy. 23 (9): 1507-1518. ...

*Transcription activator-like effector nuclease

Adoptive T-cell Immunotherapies". Cancer Research. 75 (18): 3853-64. doi:10.1158/0008-5472.CAN-14-3321. PMID 26183927. Boissel ... "A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy". Molecular Therapy. 23 (9): 1507-18. doi: ...

*Cancer

A variety of therapies using immunotherapy, stimulating or helping the immune system to fight cancer, have come into use since ... Approaches include antibodies, checkpoint therapy and adoptive cell transfer. Laser therapy uses high-intensity light to treat ... Waldmann TA (March 2003). "Immunotherapy: past, present and future". Nature Medicine. 9 (3): 269-77. doi:10.1038/nm0303-269. ...